S&P 500
$5,916.93
+0.4%
+$24.35
DJI
$42,322.75
+0.6%
+$271.69
NASDAQ
$19,112.32
-0.2%
-$34.49
Bitcoin
$104,181.00
+1.2%
+$1,253.95
AAPL
$211.11
-0.6%
-$1.22
AMZN
$204.88
-2.6%
-$5.36
GOOG
$165.24
-0.9%
-$1.57
META
$643.49
-2.4%
-$15.87
MSFT
$452.47
-0.1%
-$0.47
NVDA
$134.64
-0.5%
-$0.70
TSLA
$342.64
-1.4%
-$5.04
ImmuCell (NASDAQ: ICCC)
$5.43
(10.6%)
$0.52
Price as of May 15, 2025, 3:41 p.m. ET
ImmuCell Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ImmuCell Company Info
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.